Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain an...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Gail E, Peay, Holly L, Kroon, Eugene, Cadigan, Rosemary Jean, Meagher, Karen, Jupimai, Thidarat, Gilbertson, Adam, Fisher, Jill, Ormsby, Nuchanart Q, Chomchey, Nitiya, Phanuphak, Nittaya, Ananworanich, Jintanat, Rennie, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Research Ethics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869463/
https://www.ncbi.nlm.nih.gov/pubmed/29127137
http://dx.doi.org/10.1136/medethics-2017-104433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869463/
https://www.ncbi.nlm.nih.gov/pubmed/29127137
http://dx.doi.org/10.1136/medethics-2017-104433

Ejemplares similares